baber/WOPTO huggingface dataset:
Patent AU-2017374845-A1 (AU)
Title: Communication network with control plane network
Inventor: HUEN TAT-SING
IPC: H04L12/24
Filed: 2017-10-30
Abstract: A communication network includes nodes. The nodes are capable of communicating over a current generation network, which will include 5G before long. One, some, or all of the nodes are also capable of communicating over a previous generation network, to which 4G will be relegated before long. A third node receives a first signal from a first node over the current generation network, a second signal that is a retransmission of the first signal from a second node over the current generation network, and network dimensional parameters from the first node and/or the second node over the previous generation network. The network dimensional parameters enable the third node to determine precise locations of the first node and the second node. Using a function of the network dimensional parameters, the third node can correlate the first signal and the second signal and generate a simplified signal therefrom.
Patent AU-2017376132-A1 (AU)
Title: Electrode curable and moldable to contours of a target in bodily tissue and methods of manufacturing and placement and dispensers therefor
Inventor: FRANKE MANFRED
IPC: A61B5/0408
Filed: 2017-12-12
Abstract: An injectable electrode comprising a liquid carrier and conductive elements which molds to the contours of a target in bodily tissue andretains the shape of the target, together with methods for forming in the body, and devices and systems for use and implantation of the injectable electrode.
Patent WO-2019200423-A1 (WO)
Title: Synergistic reconfigurable traffic intersection
Inventor: LEUNG VALIANT YUK YUEN
IPC: E01C1/02
Filed: 2018-12-21
Abstract: The present invention relates to a traffic intersection and traffic guidance system therefor, that has an intersection region where two roads cross, and a distal crossover zone that allows vehicles that are turning to the right (on a left-hand-drive road) to crossover to the right hands side of the road at a distance from the intersection. In this way, a separate right turn phase is not required by the traffic lights at the intersection, and vehicles turning right can turn at the same time as vehicle moving straight over the intersection or turning left. The turning right lane approaching the distal crossover zone from a distal side of the distal crossover zone is located on the far left, allowing vehicles going straight to continue to move in a straight line. Lanes that guide vehicles moving straight are reconfigurable to guide vehicles to move in opposed directions at different time of the day, depending on the traffic loading, and are also reconfigurable as parking spaces. Bicycle lanes are also provided that are received form the intersection region between the turning right lane proximal of the distal crossover zone and the going straight lanes approaching the intersection region.
Patent AU-2018202610-A1 (AU)
Title: Room and Area Disinfection Utilizing Pulsed Light With Modulated Power Flux And Light Systems With Visible Light Compensation Between Pulses
Inventor: STIBICH MARK A
IPC: A23L3/28
Filed: 2018-04-13
Abstract: Disinfection methods and apparatuses are provided which generate pulses of germicidal light at a frequency greater than 20 Hz and project the pulses of light to surfaces at least 1.0 meter from the disinfection apparatus. The pulses of light comprise a pulse duration and an energy flux sufficient to generate a power flux between approximately 200 W/m 2 and approximately 5000 W/m 2 of ultraviolet light in the wavelength range between 200 nm and 320 nm at the surfaces. Other disinfection methods and apparatuses are provided which generate pulses of light comprising germicidal light and visible light from a germicidal light source and generate pulses of light from a visible light source that is distinct from the germicidal light source. The projections of visible light from the light sources produce a continuous stream of visible light or a collective stream of visible light pulsed at a frequency greater than 60 Hz. L l/ FIG. 4 FIG. 5 Target Ranges of Energy Flux and Power Flux of Ultraviolet Light Between -200 nm and -320 nm Pulse frequency >-20Hz -20- -1500 J/m2 -0.02- -1.5 J/m2 -6.0- -370 pJ/m 2 -1.5- -95 pJ/m2 -0.8 - -5.0 MW/m 2 -800 -~5000 W/m2 -200 - -1300 W/m2 -50 - -300 W/m 2 98 1.0 meter 2.0 meter 3.0 meter Lamp Surface
Patent AU-2018202945-A1 (AU)
Title: Wound-connection pads for fluid instillation and negative pressure wound therapy, and systems and methods
Inventor: LOCKE CHRISTOPHER
IPC: A61M27/00
Filed: 2018-04-27
Abstract: Connection pads for coupling fluid-instillation and negative pressure wound therapy (NPWT) apparatuses to wound dressing, and methods and wound dressings for breaching a drape after coupling a wound dressing to a fluid-instillation and/or NPWT apparatus. 24 36b 40a 40b
Patent AU-2018204638-A1 (AU)
Title: Fabric system
Inventor: THOMSON MATTHEW
IPC: D01F8/06
Filed: 2018-06-26
Abstract: A composite yarn comprising one or more ultra-high molecular weight polyethylene fibres wrapped around one or more polyurethane-polyurea copolymer fibres.
Patent AU-2018205994-A1 (AU)
Title: Process for the preparation of 3-substituted 5-amino-6H-Thiazolo[4,5-d]Pyrimidine-2,7-Dione Compounds
Inventor: CHEN JUNLI
IPC: C07D513/04
Filed: 2018-01-04
Abstract: The present invention relates to a process for synthesizing a compound of formula (I), R
Patent AU-2018208797-A1 (AU)
Title: Method for changing cellular communication network for an object using a uicc chip card, not requiring the chip card to be changed or reprogrammed
Inventor: DURAND ROMAIN
IPC: H04W48/02
Filed: 2018-01-18
Abstract: The present invention relates to a method for establishing a connection between an object (12) and a first cellular communication network (14A), the object (12) including a UICC chip card (20) and being connected to a second cellular communication network (14B), the UICC chip card (20) storing a list (32) of cellular communication networks that are forbidden for connection, the method comprising the following steps: a step of transmitting, by the object (12), a request to establish a connection with the second cellular communication network; a step of deleting content from the list (32) of forbidden cellular communication networks; a step (53) of notifying that communication was refused by the second cellular communication network (14B); a step of transmitting, by the object (12), a request to establish a connection with the first cellular communication network (14A); and a step of establishing the connection between the object (12) and the first cellular communication network (14A).
Patent AU-2018214148-A1 (AU)
Title: Secure and disruption-tolerant communications for unmanned underwater vehicles
Inventor: VISWANATHAN KAPALEESWARAN
IPC: H04L45/28
Filed: 2018-08-10
Abstract: SECURE AND DISRUPTION-TOLERANT COMMUNICATIONS FOR UNMANNED UNDERWATER VEHICLES An underwater communications system 110 includes a network communication interface, one or more computer processors, and a memory 150 containing computer program code that, when executed by operation of the one or more computer processors 170, performs an operation. The operation includes storing a plurality of data packets to be transmitted to a destination device, determining that data communications over the network communication interface have become available for a first network node, and determining that the first network node has a valid security credential that has not been revoked by an access granting authority. Additionally, the operation includes, upon determining that the first network node has the valid security credential, transmitting the stored plurality of data packets over the network communication interface to the first network node. The first network node is configured to employ store-carry-and-forward data messaging techniques to transmit the plurality of data packets towards the destination device. P- I - I I I I I uiI - I I I f I I F F m D I I I I I F F () F F I FI Z: w 112U 0 6 a I I I1- I I w II II I C )I I F
Patent AU-2018246235-A1 (AU)
Title: Truncated NKG2D chimeric receptors and uses thereof in natural killer cell immunotherapy
Inventor: LEONG JUN HAO
IPC: C07K14/725
Filed: 2018-03-27
Abstract: Several embodiments disclosed herein relate to the compositions comprising engineered Natural Killer (NK) cells that express a chimeric receptor, the chimeric receptor imparting to the NK cells an enhanced ability to target specific cells, such as cancerous cells or those affected by an infectious disease. Several embodiments relate to NK cells that target cells expressing natural ligands of NKG2D, where the NK cells comprise transmembrane and/or signaling domains that lead to cytotoxic and/or cytolytic effects when the NK cells bind a target cell. Uses of NK cell compositions to treat diseases are also provided for in several embodiments.
Patent AU-2018250022-A1 (AU)
Title: Systems and methods to detect catheter occlusion
Inventor: WITT ERIK K
IPC: A61M25/00
Filed: 2018-03-06
Abstract: A system to detect occlusion of an intravenous catheter may include a housing, which may include a distal end configured to couple to a proximal end of a catheter adapter and an inner lumen forming a fluid pathway. The system may also include a wave transmitter, a transducer disposed within the fluid pathway, a processor coupled to the transducer, and an indicator unit coupled to the processor. The wave transmitter may transmit energy waves along a length of an intravenous catheter of the catheter adapter. The processor may receive an electrical signal corresponding to the portion of the energy waves that are reflected back from the intravenous catheter and may determine a difference between the electrical signal and a baseline signal. In response to the difference between the electrical signal and the baseline signal meeting a threshold value, the indicator unit may alert a user.
Patent AU-2018266733-A1 (AU)
Title: Genetic signatures to predict prostate cancer metastasis and identify tumor aggressiveness
Inventor: DAVICIONI ELAI
IPC: C12Q1/6841
Filed: 2018-05-11
Abstract: The present invention relates to methods, systems and kits for the diagnosis, prognosis and the determination of cancer progression of prostate cancer in a subject. The invention also provides clinically useful genomic classifiers for predicting prostate cancer metastasis and identifying tumor aggressiveness. The methods, systems and kits can provide expression-based analysis of biomarkers for purposes of predicting metastatic disease and lethal prostate cancer in a subject. Further disclosed herein, in certain instances, are probe sets for use in predicting prostate cancer metastasis in a subject. Classifiers for predicting prostate cancer metastasis are provided. Methods of treating cancer based on tumor aggressiveness are also provided. The methods and classifiers of the present invention are also useful for predicting early prostate cancer metastasis.
Patent AU-2018272013-A1 (AU)
Title: Crystalline forms of a FGFR inhibitor and processes for preparing the same
Inventor: PAN YONGCHUN
IPC: A61K31/438
Filed: 2018-05-25
Abstract: The present disclosure relates to solid forms of N-{[2'-(2,6-difluoro-3,5-dimethoxyphenyl)-3'-oxo-2',3'-dihydro-1'H-spiro[cyclopropane-1,4'-[2,7]naphthyridin]-6'-yl]methyl}acrylamide, methods of preparation thereof, and intermediates in the preparation thereof, which are useful in the treatment of the FGFR-associated or mediated diseases such as cancer.
Patent AU-2018303175-A1 (AU)
Title: Agents, uses and methods for treatment
Inventor: BIILMANN RØNN LARS CHRISTIAN
IPC: A61K39/00
Filed: 2018-07-18
Abstract: The present invention relates to monoclonal anti-Sortilin antibodies which have been found useful in correcting a deficient level of progranulin (PGRN). In particular, these antibodies can be used in the treatment of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) and other neurodegenerative disorders such as Alzheimers disease (AD).
Patent AU-2018311636-A1 (AU)
Title: S-nitrosothiol compounds and their combinations with nitrosamine blocking agents for safe food preservation
Inventor: TIROSH OREN
IPC: A23L3/3508
Filed: 2018-07-31
Abstract: The invention relates to a process for treating food, in particular for curing meat, comprising adding to the food a compound of Formula III, which is a derivative of S-nitroso-cysteine. Use of the compound of Formula III as food preservative and compositions for curing meat are also provided by the invention.
Patent AU-2018316617-A1 (AU)
Title: Methods and apparatus for performing access and/or forwarding control in wireless networks such as WLANS
Inventor: FREI RANDALL
IPC: H04W12/08
Filed: 2018-08-16
Abstract: Methods and apparatus for controlling access to and/or forwarding of communicated information, e.g. traffic, in a wireless communication system are described. The key, e.g., PSK, used to secure data that is transmitted to an access point for communication to a destination device is taken into consideration when deciding whether or not to provide the destination device access to the communicated content. The decision of whether or not to provide the destination device access to a communication may involve deciding whether or not to forward the received data to another device, e.g., another access point, for delivery to the destination device and/or may involve deciding whether or not to transmit the data to the destination device. If the destination device is not associated with, e.g., does not have access to and/or authorization to use, the key used to secure the received data, the data is not communicated to the destination device.
Patent AU-2018347421-A1 (AU)
Title: Transgenic selection methods and compositions
Inventor: CHENG ALBERT
IPC: C07K19/00
Filed: 2018-10-11
Abstract: The present disclosure provides a split intein selectable marker system for the production and selection of transgenic cells.
Patent AU-2018394391-A1 (AU)
Title: Surgical cap with pocket
Inventor: ANTUNES NUNO
IPC: A42B1/04
Filed: 2018-12-26
Abstract: The present invention relates to a textile article (T) developed to be worn on the head by health care providers. The article is made of conventional textile materials but has specific properties for use in a hospital setting, having an outer layer composed of a semipermeable component, an inner layer composed of a breathable and antimicrobial component, and preferably an intermediate layer with an antimicrobial barrier function. Also, the presence of a pocket (P) simultaneously allows the user to store safely and temporarily small personal belongings.
Patent AU-2019201005-A1 (AU)
Title: Battery system, remaining capacity estimation device, and remaining capacity estimation method
Inventor: MATSUSHITA HIROKI
IPC: G01R31/36
Filed: 2019-02-13
Abstract: Certain embodiments provide battery system (1) including: a battery (10); a current measurement unit (20) configured to measure a current charged to or discharged from the battery (10); a voltage measurement unit (30) configured to measure an output voltage of the battery (10); a function creation unit (40) configured to create a function representing a depth-of-discharge characteristic of the battery (10) on the basis of the measured current and output voltage; and a remaining capacity calculation unit (50) configured to calculate a remaining capacity corresponding to the output voltage of the battery (10) using the created function. 11087346_1 (GHMatters) P110677.AU BATTERY SYSTEM REMAINING CAPACITY ESTIMATION DEVICE 10 20 MEASUREMENT CURRENTPOEl BATTERY DISCHARGED VOLAGECURRENT LOAD MEASUREME- MEASUREME- DEVICE FUNCTION CREATION UNIT REMAINING CAPACITY CALCULATION UNIT INPUT UNIT DISPLAY UNIT
Patent AU-2019203168-A1 (AU)
Title: Metadata-driven program code generation for clinical data analysis
Inventor: COHEN BARRY R
IPC: G16H15/00
Filed: 2019-05-06
Abstract: A computer-implemented method for analyzing clinical trial data, the method performed by at least one processor, the method including accessing, by the at least one processor, metadata that describes an input data set fora clinical trial, at least one artifact to be provided as output, and at least one operation to be performed on the input data set to create the at least one artifact, determining whether the metadata includes at least one instruction for generating program code that performs the at least one operation to create the at least one artifact, a reference to program code in a code repository that performs the at least one operation to create the at least one artifact, or program code included inline in the metadata that performs the at least one operation to create the at least one artifact, if the metadata includes at least one instruction for generating program code, executing the at least one instruction included in the metadata to generate the program code that performs the at least one operation to create the at least one artifact, if the metadata includes a reference to program code in a code repository that performs the at least one operation to create the at least one artifact retrieving at least a portion of the program code from the code repository based on the reference included in the metadata, if the metadata includes program code inline in the metadata that performs the at least one operation to create the at least one artifact, retrieving at least a portion of the program code that is included, inline, in the metadata, executing, by the at least one processor, the program code that is generated or retrieved, the executing including performing the at least one operation on the input data set, wherein executing the program code creates the at least one artifact based on the performing of the at least one operation, and communicating, by the at least one processor, the at least one artifact for presentation through a user interface of a computing device. I ---- I UU- Page 1 of 5 m o U O 0c -o c 53- co o 0 a25 < 2
Patent AU-2019218319-A1 (AU)
Title: Anti-B7-H4 antibody, antigen-binding fragment thereof and pharmaceutical use thereof
Inventor: BAO RUDI
IPC: A61K39/395
Filed: 2019-02-01
Abstract: An anti-B7-H4 antibody, an antigen-binding fragment thereof and pharmaceutical use thereof. A chimeric antibody and a humanized antibody comprising a CDR region of the anti-B7-H4 antibody, a pharmaceutical composition comprising the anti-B7-H4 antibody and the antigen-binding fragment thereof, and use thereof as an anti-cancer medicament. A humanized anti-B7-H4 antibody and use thereof in the preparation of a medicament for treating diseases or conditions mediated by B7-H4.
Patent AU-2019219081-A1 (AU)
Title: A tanning composition
Inventor: MONE REBECCA
IPC: A61K8/35
Filed: 2019-02-07
Abstract: The invention provides a tanning composition for oral administration by humans, the composition being a chewable pastille comprising: (i)a chewable base comprising a gelling agent and a sugar and/or sugar alcohol; and (ii)one or more skin colour-promoting agents. The sugar is typically a mixture of glucose and sucrose. The gelling agent may be is selected from gelatin, pectin, agar, alginate and carrageen an, and mixtures thereof. The skin colour-promoting agents may comprise one or more of the carotenoids β- carotene, lycopene, zeaxanthin, lutein and astaxanthin, tyrosine, PABA and copper.
Patent AU-2019247353-A1 (AU)
Title: A transmission arrangement for a floor surfacing machine comprising a first and second idle pulley, both pivotable around a common pivot axis
Inventor: MESINOVIC BESIM
IPC: B24B47/12
Filed: 2019-04-03
Abstract: A transmission arrangement (113) comprising a first axle (24) that is rotatable about a first axis (33) and is connected to a first pulley (25) that is arranged to drive an endless power transferring means (26) that further is adapted to drive a second pulley (27) that is rotatable about a second axis (34), where the transmission arrangement (113) comprises a first idle pulley (101) and a second idle pulley (102) which both are adapted to guide the endless power transferring means (26), where the first idle pulley (101) is rotatable around a first idle pulley axis (103) and the second idle pulley (102) is rotatable around a second idle pulley axis (104), where the distance between the idle pulley axes (103, 104) is fixed and where the idle pulley axes (103, 104) are pivotable around a common pivot axis (105), wherein the first pulley (25) is positioned between the idle pulleys (101, 102) and the second pulley (27) such that a distance between any one of the idle pulley axes (103, 104) and the second axis (34) exceeds a distance between any one of the idle pulley axes (103,104) and the first axis (33).
Patent AU-2019250120-A1 (AU)
Title: Porous interconnected corrugated carbon-based network (ICCN) composite
Inventor: HWANG JEE YOUN
IPC: C01G55/00
Filed: 2019-10-15
Abstract: Abstract A porous interconnected corrugated carbon-based network (ICCN) composite and methods for making the same are disclosed. The porous ICCN composite is made up of a plurality of carbon layers that are interconnected and expanded apart from one another to form a plurality of pores. Metallic nanoparticles are disposed within the plurality of pores. In one embodiment, a light exposure only based method for producing the porous ICCN composite is disclosed. In another embodiment a light exposure plus an electrodeposition method for producing the porous ICCN composite is disclosed. In yet another exemplary embodiment, a capacitor having a first electrode and a second electrode separated from the first electrode by a dielectric wherein at least one of the first electrode and the second electrode is formed from the porous ICCN composite is disclosed.
Patent AU-2019265346-A1 (AU)
Title: Heteroaryl compounds and uses thereof
Inventor: JANG MING-KUEI
IPC: A61K51/04
Filed: 2019-05-09
Abstract: Described herein are compounds of formula (I), and pharmaceutically acceptable salts, solvates, hydrates, isotopically labeled derivatives and radiolabeled derivative thereof, and pharmaceutical compositions thereof. Also provided are methods and kits involving the inventive compounds or compositions for detecting and imaging Tau aggregates in the brain for detection of Alzheimer's disease (AD) in a subject.
Patent AU-2019266226-A1 (AU)
Title: Novel gene classifiers and uses thereof in autoimmune diseases
Inventor: DOBAK JOHN DANIEL
IPC: A61B50/30
Filed: 2019-05-07
Abstract: Disclosed herein are methods of detecting an altered gene expression levels in a subject suspected of having an autoimmune disorder. Further described herein are methods of treating an autoimmune disorder in a subject having an exhibiting an altered gene expression level.